D.E. Shaw & Co’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100M | Buy |
3,088,450
+2,220,559
| +256% | +$72.2M | 0.07% | 217 |
|
|
2025
Q1 | $32.8M | Buy |
867,891
+92,238
| +12% | +$3.48M | 0.03% | 468 |
|
|
2024
Q4 | $63.5M | Buy |
775,653
+352,155
| +83% | +$28.8M | 0.05% | 303 |
|
|
2024
Q3 | $48.4M | Buy |
423,498
+193,291
| +84% | +$22.1M | 0.04% | 336 |
|
|
2024
Q2 | $17.4M | Sell |
230,207
-137,042
| -37% | -$10.3M | 0.02% | 634 |
|
|
2024
Q1 | $25.1M | Sell |
367,249
-71,062
| -16% | -$4.85M | 0.02% | 514 |
|
|
2023
Q4 | $27.5M | Sell |
438,311
-100,073
| -19% | -$6.28M | 0.02% | 453 |
|
|
2023
Q3 | $27.4M | Sell |
538,384
-274,528
| -34% | -$14M | 0.03% | 433 |
|
|
2023
Q2 | $40.6M | Buy |
812,912
+18,005
| +2% | +$899K | 0.04% | 314 |
|
|
2023
Q1 | $29.8M | Sell |
794,907
-177,414
| -18% | -$6.65M | 0.03% | 441 |
|
|
2022
Q4 | $46.6M | Buy |
+972,321
| New | +$46.6M | 0.05% | 282 |
|